Cowen analyst Robert Stone said the jury award in favor of VirnetX (VHC) in its patent fight with Apple (AAPL) should aid the company in signing licenses with others. Stone, who thinks talks have been underway with Android OEMs and infrastructure players and expects that the "first couple of contracts" could be signed in the coming months, keeps an Outperform rating and $36 price target on VirnetX shares.

DBDeutsche Bank

09/30/16

09/30/16NO CHANGE

Correction: Deutsche Bank credit upgraded to Neutral at BofA/Merrill

BofA/Merrill upgraded Deutsche Bank's credit to Neutral, not the equity.

09/29/16

COWN

09/29/16NO CHANGECOWN

DoJ will not destabilize Deutsche Bank, says Cowen

Cowen analyst Jaret Seiberg sees little practical or political upside for the Justice Department to press Deutsche Bank for a penalty that is so large it could destabilize the bank and create a new financial crisis. He expects the penalty for violations related to mortgage-backed securities to be structured below the speculated $14B that seems to have alarmed the market. Seiberg adds both sides have incentives to reach a deal quickly.

09/19/16

09/19/16INITIATION

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DSW (DSW) initiated with a Negative at Susquehanna. 2. Deutsche Bank (DB) initiated with an Underperform at Credit Suisse. 3. UBS (UBS) initiated with a Neutral at Credit Suisse. 4. Cerner (CERN) initiated with a Neutral at BofA/Merrill. 5. Callidus Software (CALD) reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Baird analyst Ben Kallo noted the "substantial" spread between SolarCity's (SCTY) share price and Tesla's (TSLA) acquisition price and sees it as a short-term trading opportunity as he is increasingly confident that their deal will close, pinning an 80% probability on the chance that the merger occurs. Kallo keeps a Neutral rating and $25 price target on SolarCity shares.

09/28/16

PACS

09/28/16NO CHANGEPACS

Outlook mixed for Tesla, says Pacific Crest

After conducting checks, Pacific Crest analyst Brad Erickson says that orders for Tesla's Model X have improved, and he expects the company's Q3 deliveries to be "solid." However, he believes that the company is offering "aggressive" discounts on Model 3 vehicles, and he thinks the company "faces overall ASP and margin risk," along with a questionable long-term demand outlook. Erickson remains cautious on the stock and keeps a Sector Weight rating on the shares.

09/28/16

BARD

09/28/16NO CHANGETarget $338BARDOutperform

Baird estimates Tesla to report 21,000 deliveries for Q3

Baird analyst Ben Kallo said he expects Tesla (TSLA) to report its Q3 delivery figures by early next week, possibly on Monday, October 3, and he estimates the company will report 21,000 total deliveries, including 12,000 Model S deliveries and 9,000 Model X deliveries. Kallo thinks a delivery number above 20,000 vehicles will be viewed as positive and believes "shorts may return" to Tesla after the delivery announcement as the company's acquisition of SolarCity (SCTY)progresses. The analyst keeps an Outperform rating and $338 price target on Tesla shares.

10/03/16

OPCO

10/03/16NO CHANGEOPCOPerform

Review process of SolarCity acquisition may be delayed, says Oppenheimer

Oppenheimer analyst Colin Rusch believes the SEC review process of Tesla's (TSLA) acquisition of SolarCity (SCTY) could be delayed due to recent activity, especially new litigation. Further, the analyst believes extension to the timeline is likely to work against the deal given the risk of ongoing "collaboration to trigger gun-jumping rules." Rusch reiterates a Perform rating on Tesla's shares.

ORCLOracle

09/16/16

RHCO

09/16/16NO CHANGERHCO

Oracle reported 'strong cloud results,' says SunTrust

SunTrust analyst John Rizzuto says that Oracle reported "strong cloud results." The analyst thinks that the company's cloud business is gaining "market and mind share." He predicts that the company's combined cloud and on-premises software revenue will rise 5% in fiscal 2017, up from a 2% decline in fiscal 2016. He keeps a $48 price target and Buy rating on the stock.

09/16/16

ADAM

09/16/16NO CHANGETarget $45ADAMBuy

Oracle shares cheap, cloud results positive, says Canaccord

Canaccord analyst Richard Davis said Oracle reported solid organic growth for its cloud business, including software licenses and cloud SaaS and PaaS. The analyst believes continued cloud success will weigh on margins and the decline in Hardware revenues will weigh on the overall businesses. However, Davis said Oracle shares remain sufficiently inexpensive to maintain as a Buy with a $45 price target.

09/16/16

BERN

09/16/16NO CHANGEBERN

Oracle miss due to 'transitory issues,' says Bernstein

After Oracle reported weaker than expected Q1 results, Bernstein analyst Mark Moerdler blames the miss on "transitory" factors, including foreign exchange headwinds and increased borrowing costs, as well as weakness in businesses on which the company is "less concerned with." The analyst says that the company's cloud business exceeded expectations, and he notes that its overall software revenue increased last quarter. He keeps an Outperform rating on the shares.

09/23/16

STFL

09/23/16NO CHANGESTFL

Oracle removed from Select List at Stifel

After attending Oracle's Analyst Day, Stifel analyst Brad Reback says that the company's infrastructure as a service portfolio "is still quite nascent." The analyst thinks that the company will have to significantly raise its overall capex in order to catch up with the leaders in the space. The analyst trimmed his price target on the stock to $45 from $48 and removed the stock from his Select List. However, he keeps a Buy rating on the shares.

RIGTransocean

09/23/16

FBCO

09/23/16UPGRADEFBCONeutral

Transocean upgraded to Neutral from Underperform at Credit Suisse

Credit Suisse analyst Gregory Lewis is upgraded Transocean to Neutral and raised its price target to $8 from $5. Lewis said management has been extending Transocean's duration and expects the company's diverse foot print and relationships to drive increased contracts.

09/19/16

SUSQ

09/19/16NO CHANGESUSQ

Susquehanna lowers price targets on several offshore drillers

Susquehanna analyst Charles Minervino lowered his estimates and price targets on offshore drillers by an average of 17%, citing lower crude prices, extended softness in new contracting activity, and expectations for a prolonged period of low dayrates. Minervino lowered his price target on Neutral rated companies Atwood Oceanics (ATW) to $7 from $11, Diamond Offshore (DO) to $16 from $18, Ensco (ESV) to $7 from $8, Noble Corp. (NE) to $5 from $6, Rowan (RDC) to $12 from $14, and Transocean (RIG) to $10 from $11.

09/15/16

09/15/16UPGRADE

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Transocean (RIG) upgraded to Hold from Sell at Canaccord with analyst Alex Brooks citing valuation. 2. Dick's Sporting (DKS) upgraded to Outperform from Perform at Oppenheimer analyst Brian Nagel citing the potential for better near-term sales trends as "weaker players" in sporting goods retail fail. 3. Akorn (AKRX) upgraded to Overweight from Neutral at Piper Jaffray with analyst David Amsellem saying volume trends across the company's commercial portfolio suggests the base business is "on sustainable footing." 4. Petrobras (PBR) upgraded to Neutral from Underperform at Macquarie with analyst Giacomo Romeo saying near-term liquidity is less concerning after recent divestitures, an improved political outlook, and the re-gained access to the bond market. 5. bluebird bio (BLUE) upgraded to Conviction Buy from Buy at Goldman with analyst Salveen Richter saying he expects Gen2 data versus Gen1 data at the October 13 R&D day to show substantial efficacy improvements, which is underappreciated by the Street, a full LentiGlobin update at ASH scheduled for December 3-6, the unveiling of the CAR T/gene editing programs, and two pivotal readouts in mid-17 that will result in a transition to commercial focus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Research firm M Science estimates that 93% of Netflix's grandfathered subscribers were price-affected by August-end. Based on churn indications in July and August, the firm is setting a domestic paid net subscriber addition estimate for Q3 of zero, which it noted is below the consensus estimate of 351,000 additions and below the company's guidance. Netflix shares are down 3.25% in early trading.

09/23/16

JEFF

09/23/16NO CHANGETarget $76JEFFUnderperform

Netflix survey shows price change having an impact, says Jefferies

Jefferies analyst John Janedis says his firm's survey, which targeted more than 1,100 Netflix (NFLX) subscribers that have received the price change notification, indicates the change is having an impact and that Amazon Prime (AMZN) is gaining market share. Of those surveyed, 16% who accepted the price change indicated that they would cancel their subscription if Netflix raised prices by another $1 in the next 24 months, Janedis tells investors in a research note. Further, the analyst notes that almost 50% of respondents that accepted the price change from Netflix identified Amazon Prime as another primary platform they use to watch video content. Among respondents leaving Netflix, 45% indicated that Amazon Prime will be their primary streaming platform going forward. Janedis keeps an Underperform rating on Netflix with a $76 price target.

09/26/16

UBSW

09/26/16NO CHANGETarget $92UBSWNeutral

Consumer satisfaction with competitors has caught up to Netflix, says UBS

UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.

09/27/16

JPMS

09/27/16NO CHANGETarget $125JPMSOverweight

Netflix price target raised to $125 from $116 at JPMorgan

JPMorgan analyst Doug Anmuth raised his price target for Netflix to $125 on a roll forward to his 2017 estimates. The analyst keeps an Overweight rating on the shares. The target is for December 2017.

MUMicron

$17.78

0.24 (1.37%)

09/29/16

NOMU

09/29/16NO CHANGETarget $23NOMUBuy

Nomura remains a Buyer of Micron, especially on weakness

Nomura analyst Romit Shah believes we are in the early part of a positive earnings revision cycle for Micron. The analyst raised his November earnings estimate to 17c, above consensus of 8c, but below "perceived" consensus of 20c-25c. Shah said DRAM's pricing outlook is the key driver as pricing and mix are improving. The analyst remains a buyer of Micron and reiterates his Buy rating and $23 price target.

09/16/16

09/16/16UPGRADE

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) coverage assumed with an Outperform from Neutral at Credit Suisse with analyst Edward Kelly saying he is encouraged by Wal-Mart's return to traffic growth against a deteriorating staples retail environment and its aggressive U.S. investments to solidify its position in an evolving industry. 2. Clorox (CLX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Comerica (CMA) upgraded to Conviction Buy from Neutral at Goldman with analyst Ryan Nash saying he sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. 4. Hormel Foods (HRL) upgraded to Buy from Hold at Edward Jones. 5. Micron (MU) upgraded to Buy from Neutral at Cleveland Research with analyst Kevin Rottinghaus saying Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

09/16/16

CLVD

09/16/16UPGRADECLVDBuy

Micron upgraded to Buy on sustainable DRAM and NAND at Cleveland Research

As previously reported, Cleveland Research upgraded Micron to Buy from Neutral. Analyst Kevin Rottinghaus said Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. He sees several catalysts over the next 12 months including DRAM demand outpacing bit supply growth for CY17, improved DRAM demand outlook for computing, data center, and mobile, improving execution at 20nm, Micron appearing to be second to market with 3D SSD solutions, and NAND expected to be in tight supply through 2017. Rottinghaus expects additional material positive estimate revisions over the next 6+ months.

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chesapeake Utilities (CPK) initiated with a Neutral at Ladenburg. 2. CONSOL (CNX) initiated with a Neutral at Goldman. 3. Johnson Controls (JCI) assumed with an Equal Weight at Barclays. 4. American Midstream Partners (AMID) initiated with a Buy at Janney Capital. 5. Brookfield Infrastructure (BIP) coverage resumed with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Abercrombie & Fitch (ANF) downgraded to Sell from Hold at Argus with analysts John Eade and Katelyn Bayone citing the company's third quarter miss and what they see as its "challenging sales outlook for the remainder of the year." 2. Duluth Holdings (DLTH) downgraded to Hold from Buy at Stifel and to Market Perform from Outperform at William Blair. 3. DAVIDsTEA (DTEA) downgraded to Market Perform from Outperform at BMO Capital and to Market Perform from Outperform at William Blair. 4. Hilton (HLT) downgraded to Outperform from Buy at CLSA with analyst Jon Oh citing valuation. 5. Horizon Pharma (HZNP) downgraded to Neutral from Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying the recent weakness in shares provides an "excellent entry point" ahead of several critical pipeline events that have the potential "to transform this giant into an exciting growth story." 2. Autodesk (ADSK) upgraded to Buy from Hold at Canaccord with analyst Richard Davis citing expectations for improved free cash flow, as he sees a path to $6 in FCF by 2020 and $11 per share in 2022. 3. Eaton (ENT) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying optionality of the company's balance sheet should offset broad weakness across its end markets. 4. Fluor (FLR) upgraded to Buy from Neutral at Citi with analyst Andrew Kaplowitz saying the company is positioned to outperform given amid oil and gas capex stabilization, a lift off the bottom in mining off the bottom and "muted" 2017 expectations. 5. Sysco (SYY) upgraded to Neutral from Sell at Goldman. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.